High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
809.17M
-4.51%
2.280
-31.12%
918.22M
-4.55%
3.695
-37.27%
841.68M
-5.46%
2.790
-26.58%
Estimates Revision
The market is revising Downward the revenue expectations for Matson, Inc. (MATX) for FY2025, with the revenue forecasts being adjusted by -7.56% over the past three months. During the same period, the stock price has changed by 9.89%.
Revenue Estimates for FY2025
Revise Downward
-7.56%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-9.99%
In Past 3 Month
Stock Price
Go Up
+9.89%
In Past 3 Month
3 Analyst Rating
0Wall Street analysts forecast MATX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MATX is 138.33 USD with a low forecast of 130.00 USD and a high forecast of 150.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
0Current: 103.850
Low
130.00
Averages
138.33
High
150.00
0Current: 103.850
Low
130.00
Averages
138.33
High
150.00
Stephens & Co.
Daniel Imbro
Buy
Maintains
$165 → $175
2025-02-26
Reason
Stephens & Co.
Daniel Imbro
Price Target
$165 → $175
2025-02-26
Maintains
Buy
Reason
Stifel
Benjamin Nolan
Hold
Maintains
$150 → $160
2025-02-26
Reason
Stifel
Benjamin Nolan
Price Target
$150 → $160
2025-02-26
Maintains
Hold
Reason
Stephens & Co.
Daniel Imbro
Buy
Reiterates
$165
2025-01-02
Reason
Stephens & Co.
Daniel Imbro
Price Target
$165
2025-01-02
Reiterates
Buy
Reason
Stephens analysts presented the firm's 2025 Best Ideas list, which includes Valley National (VLY), CoStar Group (CSGP), Castle Biosciences (CSTL), Alignment Healthcare (ALHC), Privia Health (PRVA), Vulcan Materials (VMC), South State (SSB), Matson (MATX), Azenta (AZTA), Prog Holdings (PRG), Carvana (CVNA), Blueprint Medicines (BPMC), Truist Financial (TFC), Cognex (CGNX), Fiserv (FI), Hancock Whitney (HWC), SunOpta (STKL), Wingstop (WING), SM Energy (SM), The Andersons (ANDE) and Bank of Marin (BMRC).
Wolfe Research
Jacob Lacks
Buy
to
Hold
Downgrades
n/a
2024-11-18
Reason
Wolfe Research
Jacob Lacks
Price Target
n/a
2024-11-18
Downgrades
Buy
to
Hold
Reason
Wolfe Research downgraded Matson to Peer Perform from Outperform. The firm cites valuation for the downgrade. Matson has materially outperformed this year, and the stock is now trading in line with historical valuation levels on Wolfe's view of normalized earnings, the analyst tells investors in a research note. The firm also sees potential tariff risk under a Trump administration.
Stephens & Co.
Jack Atkins
Buy
Maintains
$155 → $160
2024-08-02
Reason
Stephens & Co.
Jack Atkins
Price Target
$155 → $160
2024-08-02
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Matson Inc (MATX.N) is 10.71, compared to its 5-year average forward P/E of 8.46. For a more detailed relative valuation and DCF analysis to assess Matson Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
8.46
Current PE
10.71
Overvalued PE
11.99
Undervalued PE
4.93
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
5.90
Current EV/EBITDA
7.03
Overvalued EV/EBITDA
7.92
Undervalued EV/EBITDA
3.87
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
0.99
Current PS
1.11
Overvalued PS
1.21
Undervalued PS
0.76
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 1763.35% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
MATX News & Events
Events Timeline
(ET)
2025-07-18
10:00:24
New
Matson falls -5.4%
2025-06-26 (ET)
2025-06-26
16:11:05
Matson raises quarterly dividend to 36c from 34c per share
2025-05-05 (ET)
2025-05-05
16:08:34
Matson reports Q1 EPS $2.18, consensus $2.27
Sign Up For More Events
Sign Up For More Events
News
Preview
8.0
07-10NASDAQ.COMWhy Matson is the 'Top Dividend Stock of the Dow Transports' With 1.3% Yield (MATX)
Preview
2.0
07-10NewsfilterMATSON PUBLISHES 2024 SUSTAINABILITY REPORT
Preview
8.0
06-27NASDAQ.COMDaily Dividend Report: LNN,SAND,MATX,SM,AZZ
Sign Up For More News
People Also Watch
FAQ
What is Matson Inc (MATX) stock price today?
What is Matson Inc (MATX)'s business?
What is the price predicton of MATX Stock?
What is Matson Inc (MATX)'s revenue for the last quarter?
What is Matson Inc (MATX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Matson Inc (MATX)'s fundamentals?
How many employees does Matson Inc (MATX). have?